A NEW HOPE FOR BODY CONTROL ?

Scientists are excitedly examining retatrutide, a innovative medication created by Eli Lilly, as a possible advance in weight loss . Different than many existing approaches, retatrutide is a dual -action receptor targeting both GLP-1 and GIP, hormones that impact hunger and blood glucose control